HWM
GILD icon

HB Wealth Management’s Gilead Sciences GILD Stock Holding History

HB Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46M Sell
51,132
-5,838
-10% -$769K 0.04% 237
2026
Q1 		$7.94M Buy
56,970
+5,516
+11% +$772K 0.05% 186
2025
Q4 		$6.32M Buy
51,454
+4,266
+9% +$518K 0.04% 225
2025
Q3 		$5.24M Buy
47,188
+13,249
+39% +$1.51M 0.04% 246
2025
Q2 		$3.76M Sell
33,939
-19
-0.1% -$2.02K 0.03% 263
2025
Q1 		$3.81M Buy
33,958
+7,547
+29% +$779K 0.03% 267
2024
Q4 		$2.44M Buy
26,411
+8,406
+47% +$757K 0.02% 251
2024
Q3 		$1.51M Sell
18,005
-380
-2% -$29K 0.02% 315
2024
Q2 		$1.26M Buy
18,385
+2,135
+13% +$142K 0.01% 325
2024
Q1 		$1.19M Sell
16,250
-2,333
-13% -$179K 0.02% 323
2023
Q4 		$1.51M Buy
18,583
+2,689
+17% +$209K 0.02% 267
2023
Q3 		$1.19M Buy
15,894
+4,222
+36% +$325K 0.02% 279
2023
Q2 		$900K Buy
11,672
+93
+0.8% +$7.42K 0.01% 306
2023
Q1 		$961K Buy
11,579
+572
+5% +$47.4K 0.02% 293
2022
Q4 		$945K Buy
11,007
+2,129
+24% +$169K 0.02% 292
2022
Q3 		$548K Buy
8,878
+1,666
+23% +$105K 0.01% 326
2022
Q2 		$446K Buy
7,212
+27
+0.4% +$1.67K 0.01% 365
2022
Q1 		$427K Buy
7,185
+3,316
+86% +$212K 0.01% 374
2021
Q4 		$281K Buy
+3,869
New +$266K 0.01% 402

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HB Wealth Management's GILD Position: Q2 2026 in Review

HB Wealth Management reduced its Gilead Sciences (GILD) stake by 10% in Q2 2026, selling an estimated $769K and leaving 51,132 shares worth $6.46M. The position accounts for 0.04% of the portfolio, ranked #237.

HB Wealth Management first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.94M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HB Wealth Management held 51,132 shares of Gilead Sciences worth $6.46M as of Q2 2026.
  • HB Wealth Management sold 5,838 Gilead Sciences shares in Q2 2026, an estimated $769K.
  • Gilead Sciences made up 0.04% of HB Wealth Management's portfolio in Q2 2026, its #237 holding.
  • HB Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • HB Wealth Management's Gilead Sciences position peaked at $7.94M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.